Published in J Nutr Biochem on March 23, 2012
High fat diet subverts hepatocellular iron uptake determining dysmetabolic iron overload. PLoS One (2015) 1.44
Iron and diabetes risk. Cell Metab (2013) 1.36
Nitric oxide-mediated regulation of ferroportin-1 controls macrophage iron homeostasis and immune function in Salmonella infection. J Exp Med (2013) 1.22
High Fat Diet Induces Liver Steatosis and Early Dysregulation of Iron Metabolism in Rats. PLoS One (2013) 0.96
Dysregulation of iron and copper homeostasis in nonalcoholic fatty liver. World J Hepatol (2015) 0.95
Obesity as an emerging risk factor for iron deficiency. Nutrients (2014) 0.95
Obesity alters adipose tissue macrophage iron content and tissue iron distribution. Diabetes (2013) 0.90
Testing the iron hypothesis in a mouse model of atherosclerosis. Cell Rep (2013) 0.85
Curcumin may impair iron status when fed to mice for six months. Redox Biol (2014) 0.81
Diet-induced obese rats have higher iron requirements and are more vulnerable to iron deficiency. Eur J Nutr (2013) 0.79
Comparative Evaluation of Iron Deficiency among Obese and Non-obese Children. Iran J Ped Hematol Oncol (2014) 0.78
Iron excess disturbs metabolic status and relative gonad mass in rats on high fat, fructose, and salt diets. Biol Trace Elem Res (2012) 0.78
Obesity promotes alterations in iron recycling. Nutrients (2015) 0.75
Genetic and Dietary Iron Overload Differentially Affect the Course of Salmonella Typhimurium Infection. Front Cell Infect Microbiol (2017) 0.75
Modulation of urinary siderophores by the diet, gut microbiota and inflammation in mice. J Nutr Biochem (2016) 0.75
Interactive effects of dietary fat/carbohydrate ratio and body mass index on iron deficiency anemia among Taiwanese women. Nutrients (2014) 0.75
Heterozygous Hfe gene deletion leads to impaired glucose homeostasis, but not liver injury in mice fed a high-calorie diet. Physiol Rep (2016) 0.75
Hepatic iron storage is related to body adiposity and hepatic inflammation. Nutr Metab (Lond) (2017) 0.75
Nutritional approaches for managing obesity-associated metabolic diseases. J Endocrinol (2017) 0.75
Local proliferation dominates lesional macrophage accumulation in atherosclerosis. Nat Med (2013) 4.14
Ghrelin octanoylation mediated by an orphan lipid transferase. Proc Natl Acad Sci U S A (2008) 3.41
Autocrine formation of hepcidin induces iron retention in human monocytes. Blood (2007) 2.50
Regulation of iron homeostasis in anemia of chronic disease and iron deficiency anemia: diagnostic and therapeutic implications. Blood (2009) 2.41
Interferon-gamma limits the availability of iron for intramacrophage Salmonella typhimurium. Eur J Immunol (2008) 2.25
Erythropoietin contrastingly affects bacterial infection and experimental colitis by inhibiting nuclear factor-κB-inducible immune pathways. Immunity (2011) 2.20
Innate response activator B cells protect against microbial sepsis. Science (2012) 2.07
Up-regulation of neutrophil gelatinase-associated lipocalin in colorectal cancer predicts poor patient survival. World J Surg (2014) 1.98
The struggle for iron - a metal at the host-pathogen interface. Cell Microbiol (2010) 1.97
Novel ghrelin assays provide evidence for independent regulation of ghrelin acylation and secretion in healthy young men. J Clin Endocrinol Metab (2008) 1.96
Macroscopic postmortem findings in 235 surgical intensive care patients with sepsis. Anesth Analg (2009) 1.95
Cytokine-mediated regulation of iron transport in human monocytic cells. Blood (2003) 1.93
Duodenal HFE expression and hepcidin levels determine body iron homeostasis: modulation by genetic diversity and dietary iron availability. J Mol Med (Berl) (2004) 1.73
Ca2+ channel blockers reverse iron overload by a new mechanism via divalent metal transporter-1. Nat Med (2007) 1.73
Association between increased iron stores and impaired endothelial function in patients with hereditary hemochromatosis. J Am Coll Cardiol (2002) 1.65
TROP2: a novel prognostic marker in squamous cell carcinoma of the oral cavity. Mod Pathol (2007) 1.63
Pharmacologic inhibition of hepcidin expression reverses anemia of chronic inflammation in rats. Blood (2011) 1.63
MRI-based liver iron content predicts for nonrelapse mortality in MDS and AML patients undergoing allogeneic stem cell transplantation. Clin Cancer Res (2012) 1.58
Arrhythmias and increased neuro-endocrine stress response during physicians' night shifts: a randomized cross-over trial. Eur Heart J (2009) 1.55
Histologic pathologies of the myocardium in septic shock: a prospective observational study. Shock (2013) 1.55
The co-ordinated regulation of iron homeostasis in murine macrophages limits the availability of iron for intracellular Salmonella typhimurium. Cell Microbiol (2007) 1.51
Increased expression of CCL20 in human inflammatory bowel disease. J Clin Immunol (2004) 1.50
The arachidonic acid metabolome serves as a conserved regulator of cholesterol metabolism. Cell Metab (2014) 1.47
Monoclonal antibody clearance. Impact of modulating the interaction of IgG with the neonatal Fc receptor. J Biol Chem (2006) 1.42
Quantitation of hepcidin from human and mouse serum using liquid chromatography tandem mass spectrometry. Blood (2007) 1.41
[Psychotropic drugs and diabetes]. Wien Med Wochenschr (2011) 1.40
Absence of functional Hfe protects mice from invasive Salmonella enterica serovar Typhimurium infection via induction of lipocalin-2. Blood (2009) 1.40
Lipocalin 2 deactivates macrophages and worsens pneumococcal pneumonia outcomes. J Clin Invest (2013) 1.32
Behavioral, biochemical, and genetic analysis of iron metabolism in high-intensity blood donors. Transfusion (2008) 1.32
The complex interplay of iron metabolism, reactive oxygen species, and reactive nitrogen species: insights into the potential of various iron therapies to induce oxidative and nitrosative stress. Free Radic Biol Med (2013) 1.30
Anti-inflammatory effects of excessive weight loss: potent suppression of adipose interleukin 6 and tumour necrosis factor alpha expression. Gut (2010) 1.30
Humanized IgG1 variants with differential binding properties to the neonatal Fc receptor: relationship to pharmacokinetics in mice and primates. Drug Metab Dispos (2006) 1.28
Pathways underlying iron accumulation in human nonalcoholic fatty liver disease. Am J Clin Nutr (2008) 1.25
Nitric oxide-mediated regulation of ferroportin-1 controls macrophage iron homeostasis and immune function in Salmonella infection. J Exp Med (2013) 1.22
Dysregulated monocyte iron homeostasis and erythropoietin formation in patients with anemia of chronic disease. Blood (2006) 1.18
Slc11a1 limits intracellular growth of Salmonella enterica sv. Typhimurium by promoting macrophage immune effector functions and impairing bacterial iron acquisition. Cell Microbiol (2009) 1.15
Prognostic significance of Ep-CAM AND Her-2/neu overexpression in invasive breast cancer. Int J Cancer (2002) 1.13
Role of IL-10 for induction of anemia during inflammation. J Immunol (2002) 1.13
Pathways for the regulation of interferon-gamma-inducible genes by iron in human monocytic cells. J Leukoc Biol (2003) 1.12
Up-regulation of functional chemokine receptor CCR3 in human renal cell carcinoma. Clin Cancer Res (2005) 1.11
Influence of visceral obesity and liver fat on vascular structure and function in obese subjects. Obesity (Silver Spring) (2009) 1.08
Copper availability contributes to iron perturbations in human nonalcoholic fatty liver disease. Gastroenterology (2008) 1.07
Blockade of the Fas/FasL system improves pneumococcal clearance from the lungs without preventing dissemination of bacteria to the spleen. J Infect Dis (2005) 1.06
Adipose and liver expression of interleukin (IL)-1 family members in morbid obesity and effects of weight loss. Mol Med (2011) 1.06
Characterization of antigen-presenting cells in fresh and cultured human corneas using novel dendritic cell markers. Invest Ophthalmol Vis Sci (2007) 1.05
Nramp1 functionality increases inducible nitric oxide synthase transcription via stimulation of IFN regulatory factor 1 expression. J Immunol (2003) 1.05
Adiponectin and its receptors in patients with chronic hepatitis C. J Hepatol (2005) 1.04
Glycosylation of erythropoietin affects receptor binding kinetics: role of electrostatic interactions. Biochemistry (2002) 1.04
Neonatal Fc receptor mediates internalization of Fc in transfected human endothelial cells. Mol Biol Cell (2008) 1.04
Thromboembolic complications after splenectomy for hematologic diseases. Am J Hematol (2004) 1.04
Pathogenesis and treatment of anemia in inflammatory bowel disease. Haematologica (2010) 1.04
Identification of a common variant in the TFR2 gene implicated in the physiological regulation of serum iron levels. Hum Mol Genet (2010) 1.03
Growth differentiation factor 15 in anaemia of chronic disease, iron deficiency anaemia and mixed type anaemia. Br J Haematol (2009) 1.03
Fas ligand-induced murine pulmonary inflammation is reduced by a stable decoy receptor 3 analogue. Immunology (2003) 1.03
Mechanisms of iron mediated regulation of the duodenal iron transporters divalent metal transporter 1 and ferroportin 1. Blood Cells Mol Dis (2003) 1.03
Retinol-binding protein 4, visceral fat, and the metabolic syndrome: effects of weight loss. Obesity (Silver Spring) (2008) 1.03
An apolipoprotein A-I mimetic dose-dependently increases the formation of prebeta1 HDL in human plasma. J Lipid Res (2007) 1.02
Body adiposity index and other indexes of body composition in the SAPHIR study: association with cardiovascular risk factors. Obesity (Silver Spring) (2013) 1.02
Lipocalin-2 ameliorates granulocyte functionality. Eur J Immunol (2012) 1.02
The RANKL/OPG system and bone mineral density in patients with chronic liver disease. J Hepatol (2005) 1.01
Kupffer cells modulate iron homeostasis in mice via regulation of hepcidin expression. J Mol Med (Berl) (2008) 1.01
Mass spectrometry analysis of hepcidin peptides in experimental mouse models. PLoS One (2011) 1.00
The macrophage: a cellular factory at the interphase between iron and immunity for the control of infections. Biometals (2005) 0.99